Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

7.7%

99 terminated/withdrawn out of 1283 trials

Success Rate

88.4%

+1.8% vs industry average

Late-Stage Pipeline

11%

136 trials in Phase 3/4

Results Transparency

1%

11 of 756 completed trials have results

Key Signals

140 recruiting11 with results74 terminated25 withdrawn

Enrollment Performance

Analytics

N/A
533(64.9%)
Phase 4
98(11.9%)
Phase 2
95(11.6%)
Phase 1
45(5.5%)
Phase 3
38(4.6%)
Early Phase 1
12(1.5%)
821Total
N/A(533)
Phase 4(98)
Phase 2(95)
Phase 1(45)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (1283)

Showing 20 of 1283 trials
NCT07634016Recruiting

Global Healthcare Study on Psoriasis

Role: collaborator

NCT07659769Recruiting

Global Healthcare Study on Hidradenitis Suppurativa

Role: collaborator

NCT01571531Recruiting

European Multicentre Study of Human Spinal Cord Injury

Role: lead

NCT07158086Recruiting

Molecular Underpinnings of Heart Failure, Integrative Multi-Omics, and Non-Coding RNA Profiling

Role: lead

NCT06435858Phase 2Completed

Short-term Effects of an SGLT2 Inhibitor on Divalent Ions in Autosomal Dominant Polycystic Kidney Disease

Role: collaborator

NCT07832123Phase 2Not Yet Recruiting

Safusidenib for Patients With Newly Diagnosed IDH1-mutant CNS WHO Grade 3 Oligodendroglioma and Astrocytoma - a Single Arm Phase II Study

Role: lead

NCT06804655Phase 2Recruiting

Pharmacoscopy for Patients With Refractory Primary Brain Tumors

Role: lead

NCT07830069Not ApplicableNot Yet Recruiting

Advanced Neurofeedback for Tinnitus

Role: lead

NCT06344871Not ApplicableTerminated

Exploratory Study Using a New Head-only PET Scanner / ExploreNeuroLF

Role: collaborator

NCT07816978Phase 4Not Yet Recruiting

Reduced-Dose Versus Full-Dose Alteplase for High-Risk Pulmonary Embolism

Role: collaborator

NCT06177938Not ApplicableCompleted

Lactobreath: A Study to Diagnose Lactose Intolerance Using Breath Markers

Role: collaborator

NCT07769983Phase 1Enrolling By Invitation

RENEW-SHCS: Safety and Immunogenicity of a Recombinant HIV Env Protein Vaccine in ARV-treated Adults Living With HIV in the SHCS

Role: lead

NCT07815366Not ApplicableEnrolling By Invitation

Effectiveness of Eccentric Cycling Exercise in Ambulatory Rehabilitation for Patients With Cardiopulmonary Diseases: A Pragmatic Randomized Controlled Trial

Role: lead

NCT07063563Not ApplicableCompleted

Effect of Rehabilitation at Moderate Altitude on Airway Resistance Measured With Forced Oscillation Technique in COPD-patients

Role: collaborator

NCT07028983Not ApplicableRecruiting

Fighting Addictions, Improving Lives: COmprehensive Drug Rehabilitation With Music

Role: collaborator

NCT07044843Not ApplicableCompleted

Oxygen Therapy During Exercise Training in Inpatient Rehabilitation in Chronic Lung Disease- Does it Matter?

Role: collaborator

NCT06663826Completed

Development of Digital Diagnostic Devices for Parkinson's Disease

Role: collaborator

NCT06027333Recruiting

Self-efficacy and Well-being of Patients With Fibrotic Interstitial Lung Disease

Role: collaborator

NCT03394612Phase 2Completed

Study With an Autologous Dermo-epidermal Skin Substitute for the Treatment of Full-Thickness Skin Defects in Adults and Children

Role: collaborator

NCT07783074Recruiting

Fatigue Investigation Using Digital Outcomes

Role: collaborator